PBYI (STOCKS)
PUMA BIOTECHNOLOGY INC
$6.800000
+0.160000 (+2.41%)
Prev close: $6.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Alan H. Auerbach
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $342.91M
- Employees
- 172
- P/E (TTM)
- 8.96
- P/B (TTM)
- 2.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.17 | $0.05 | +0.1241 | +270.37% |
|
Jun 2025 (Q2)
|
$0.12 | $0.10 | +0.0153 | +14.61% |
|
Mar 2025 (Q1)
|
$0.06 | $-0.02 | +0.0804 | +394.12% |
|
Dec 2024 (Q4)
|
$0.39 | $0.10 | +0.2853 | +272.49% |
Financial Statements
| Assets | $202.86M |
| Current Assets | $143.58M |
| Cash | $88.43M |
| Inventory | $9.48M |
| Prepaid Expenses | $3.83M |
| Other Current Assets | $41.85M |
| Noncurrent Assets | $59.28M |
| Fixed Assets | $305.00K |
| Other Non-current Assets | $58.98M |
| Liabilities | $87.59M |
| Current Liabilities | $82.73M |
| Accounts Payable | $6.39M |
| Wages | $5.42M |
| Other Current Liabilities | $70.92M |
| Noncurrent Liabilities | $4.87M |
| Long-term Debt | $34.01M |
| Equity | $115.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $115.27M |
| Liabilities And Equity | $202.86M |